We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

250 hedge funds and large institutions have $6.76B invested in PHARMACYCLICS INC in 2014 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 86 increasing their positions, 87 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 68 (+2)

33% more capital invested

Capital invested by funds: $5.08B → $6.76B (+$1.68B)

0% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 33

0% less funds holding

Funds holding: 251250 (-1)

1% less repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 87

42% less call options, than puts

Call options by funds: $144M | Put options by funds: $248M

Holders
250
Holders Change
-1
Holders Change %
-0.4%
% of All Funds
7.25%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.23%
New
33
Increased
86
Reduced
87
Closed
33
Calls
$144M
Puts
$248M
Net Calls
-$104M
Net Calls Change
-$62M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.15B +$236M +2,074,585 +27%
BBA
2
Baker Bros. Advisors
New York
$1.13B +$7.41M +65,053 +0.7%
Ameriprise
3
Ameriprise
Minnesota
$529M +$28.2M +247,158 +6%
JHIU
4
Janus Henderson Investors US
Colorado
$448M +$67.2M +589,582 +18%
Vanguard Group
5
Vanguard Group
Pennsylvania
$413M +$5.31M +46,553 +1%
Capital World Investors
6
Capital World Investors
California
$291M -$57M -500,000 -17%
Primecap Management
7
Primecap Management
California
$271M -$228K -2,000 -0.1%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$235M -$40.5M -355,679 -15%
BIT
9
BlackRock Institutional Trust
California
$180M -$14.6M -128,217 -8%
State Street
10
State Street
Massachusetts
$135M -$3.25M -28,540 -2%
FAM
11
Fred Alger Management
New York
$119M -$52.6M -461,120 -31%
Federated Hermes
12
Federated Hermes
Pennsylvania
$96.8M +$42.9M +376,148 +84%
BB
13
BB Biotech
Switzerland
$85.9M
First Trust Advisors
14
First Trust Advisors
Illinois
$84.6M +$8.87M +77,844 +12%
CCM
15
Cornerstone Capital Management
Minnesota
$81.2M -$1.86M -16,295 -2%
MAA
16
Managed Account Advisors
New Jersey
$70.6M +$8.17M +71,651 +14%
Norges Bank
17
Norges Bank
Norway
$68.6M -$68.4M -600,347 -51%
Morgan Stanley
18
Morgan Stanley
New York
$65.8M +$1.35M +11,814 +2%
Goldman Sachs
19
Goldman Sachs
New York
$56.9M -$25.9M -226,924 -32%
BFA
20
BlackRock Fund Advisors
California
$56.2M +$954K +8,370 +2%
UBS AM
21
UBS AM
Illinois
$47.4M +$1.27M +11,142 +3%
AllianceBernstein
22
AllianceBernstein
Tennessee
$45.7M +$1.54M +13,473 +4%
Northern Trust
23
Northern Trust
Illinois
$43.3M -$5.39M -47,308 -11%
RFC
24
Russell Frank Company
Washington
$40.8M +$8.46M +74,200 +27%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$39.6M -$1.18M -10,390 -3%

PCYC Hedge Fund Activity: Q3 2014 in Review

250 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q3 2014, worth a combined $6.76B — up 33% from $5.08B a quarter earlier.

Fund positioning in PCYC was balanced in Q3 2014: 33 funds opened new positions, 33 closed out, 86 added to existing stakes and 87 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $236M. The largest seller was Norges Bank, cutting an estimated $68.4M.

  • 250 institutional investors held PHARMACYCLICS INC (PCYC) as of Q3 2014, down from 251 in Q2 2014.
  • Funds reported $6.76B of PHARMACYCLICS INC stock for Q3 2014, up 33% quarter-over-quarter.
  • 33 funds opened new PHARMACYCLICS INC positions in Q3 2014 and 33 closed out, a net change of 0 holders.
  • The largest PHARMACYCLICS INC buyer in Q3 2014 was T. Rowe Price Associates, an estimated $236M added.
  • The largest PHARMACYCLICS INC seller in Q3 2014 was Norges Bank, an estimated $68.4M sold.

Based on aggregated 13F filings for Q3 2014.